Literature DB >> 2613166

Cystadenoma and cystadenocarcinoma of the pancreas.

H Katoh1, R L Rossi, J W Braasch, J L Munson, E Shimozawa, T Tanabe.   

Abstract

During the period 1963 to 1988, we treated 45 patients with cystic neoplasms of the pancreas. The patients were divided into group 1, which included 26 patients treated between 1963 and 1983, and group 2, which included 19 patients treated between 1984 and 1988. The rate of resection for cystadenoma was 67% for group 1 (n = 15) and 100% for group 2 (n = 11). The operative mortality rate was 0% for both groups. Pathologically, 17 patients (69%) had serous cystadenoma and nine (31%) mucinous adenoma. Except for 5 of the 15 patients from group 1 who died of other causes, all patients are healthy. The resection rate for cystadenocarcinoma was 36% for group 1 (n = 11) and 100% for group 2 (n = 8). In 2 patients from group 1 and 1 patient from group 2, the tumors had been diagnosed previously as benign by operative biopsy of the cyst wall. There was no operative mortality in either group. Cystic neoplasm was suspected from the results of ultrasonography and computed tomography in 70% of the patients in group 2. In 2 patients (25%), the preoperative diagnosis of pseudocyst associated with chronic pancreatitis was made. Adenocarcinoma was diagnosed in 3 patients by needle biopsy and cytologic examination of pancreatic juice. Eighty-two percent (9 patients) of group 1 died of recurrent carcinoma; 2 patients were alive without disease at 5 and 8 years. Thirty-eight percent (3 patients) of patients in group 2 died of recurrent carcinoma, two patients died of other causes, and 3 patients are still alive.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2613166

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

Review 1.  A case of macrocystic serous cystadenoma of the pancreas.

Authors:  K Mori; S Takeyama; H Hirosawa; T Watanabe; T Taniya; H Arakawa; T Nagakawa; T Ohta; I Miyazaki; Y Nakanuma
Journal:  Int J Pancreatol       Date:  1995-02

2.  Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients.

Authors:  A L Warshaw; C C Compton; K Lewandrowski; G Cardenosa; P R Mueller
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

3.  Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms?

Authors:  M G Sarr; H A Carpenter; L P Prabhakar; T F Orchard; S Hughes; J A van Heerden; E P DiMagno
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

4.  Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients.

Authors:  C Azar; J Van de Stadt; F Rickaert; M Devière; M Baize; G Klöppel; M Gelin; M Cremer
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

5.  The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects.

Authors:  C M Pyke; J A van Heerden; T V Colby; M G Sarr; A L Weaver
Journal:  Ann Surg       Date:  1992-02       Impact factor: 12.969

6.  miR‑224‑5p regulates the proliferation, migration and invasion of pancreatic mucinous cystadenocarcinoma by targeting PTEN.

Authors:  Xiaobo Peng; Chengtao Guo; Yanjun Wu; Mingzhen Ying; Renxu Chang; Lele Song; Lixing Zhan; Xianbao Zhan
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.